WPP Names Philip Jansen Non-Executive Chair-February 2024-www.financetom.com

WPP Names Philip Jansen Non-Executive Chair

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

WPP Names Philip Jansen Non-Executive Chair

Jul 30, 2024 8:19 AM

10:56 AM EDT, 07/30/2024 (MT Newswires) -- WPP ( WPP ) said Tuesday it has appointed Philip Jansen as non-executive chair designate and to the board.

Jansen is expected to join the board on Sept. 16, and will succeed Roberto Quarta as non-executive chair on Jan. 1, WPP ( WPP ) said.

Quarta is retiring, the company said.

Price: 48.16, Change: +0.49, Percent Change: +1.03

Previous page： Taiwan's spending bonanza draws more foreign firms to its largest arms show Next page： Hollywood comes to Kimmel's defense after ABC pulls late-night show

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Taiwan's spending bonanza draws more foreign firms to its largest arms show

Sep 17, 2025

* Taiwan opens once-every-two-years arms show * Largest ever number of U.S. companies taking part * Taiwan bolstering its defences as threat from China rises By Yimou Lee and Ben Blanchard TAIPEI, Sept 18 (Reuters) - Taiwan opened its largest arms fair on Thursday, with about double its previous number of exhibitors, as firms flock for a slice of the...

Hollywood comes to Kimmel's defense after ABC pulls late-night show

Sep 17, 2025

* ABC pulls Jimmy Kimmel Live amid regulatory threats * Unions claim suspension attacks free speech rights * Trump administration pressures broadcasters over Kimmel's comments By Dawn Chmielewski LOS ANGELES, Sept 18 (Reuters) - Hollywood blasted the White House for targeting free speech after ABC pulled Jimmy Kimmel's talk on Wednesday under regulatory threats from Donald Trump's administration, rallying behind...

89bio, Inc. Announces Agreement to be Acquired by Roche

Sep 17, 2025

– 89bio stockholders to receive up to $20.50 per share in cash, comprised of $14.50 per share in cash at closing and a non-tradeable contingent value right (CVR) to receive up to an aggregate of $6.00 per share in cash; transaction represents total equity value of up to approximately $3.5 billion – – Transaction reflects pegozafermin’s potential best-in-disease profile for...

Roche to acquire liver drug developer 89bio for up to $3.5 billion

Sep 17, 2025

FRANKFURT (Reuters) -Roche said on Thursday it agreed to acquire U.S. biotech firm 89bio ...